Revealing  ||| S:0 E:10 ||| VBG
parasite  ||| S:10 E:19 ||| JJ
influence  ||| S:19 E:29 ||| NN
in  ||| S:29 E:32 ||| IN
metabolic  ||| S:32 E:42 ||| JJ
pathways  ||| S:42 E:51 ||| NN
in  ||| S:51 E:54 ||| IN
Apicomplexa  ||| S:54 E:66 ||| NNP
infected  ||| S:66 E:75 ||| JJ
patients  ||| S:75 E:84 ||| NNS
As  ||| S:84 E:87 ||| IN
an  ||| S:87 E:90 ||| DT
obligate  ||| S:90 E:99 ||| JJ
intracellular  ||| S:99 E:113 ||| JJ
parasite ||| S:113 E:121 ||| NN
,  ||| S:121 E:123 ||| ,
Apicomplexa  ||| S:123 E:135 ||| NNP
interacts  ||| S:135 E:145 ||| NN
with  ||| S:145 E:150 ||| IN
the  ||| S:150 E:154 ||| DT
host  ||| S:154 E:159 ||| NN
in  ||| S:159 E:162 ||| IN
the  ||| S:162 E:166 ||| DT
special  ||| S:166 E:174 ||| JJ
living  ||| S:174 E:181 ||| NN
environment ||| S:181 E:192 ||| NN
,  ||| S:192 E:194 ||| ,
competing  ||| S:194 E:204 ||| VBG
for  ||| S:204 E:208 ||| IN
energy  ||| S:208 E:215 ||| NN
and  ||| S:215 E:219 ||| CC
nutrients  ||| S:219 E:229 ||| NN
from  ||| S:229 E:234 ||| IN
the  ||| S:234 E:238 ||| DT
host  ||| S:238 E:243 ||| NN
cells  ||| S:243 E:249 ||| NNS
by  ||| S:249 E:252 ||| IN
manipulating  ||| S:252 E:265 ||| VBG
the  ||| S:265 E:269 ||| DT
host  ||| S:269 E:274 ||| NN
metabolism ||| S:274 E:284 ||| NN
.  ||| S:284 E:286 ||| .
Previous  ||| S:286 E:295 ||| JJ
studies  ||| S:295 E:303 ||| NNS
of  ||| S:303 E:306 ||| IN
host-parasite  ||| S:306 E:320 ||| JJ
interaction  ||| S:320 E:332 ||| NNS
mainly  ||| S:332 E:339 ||| RB
focused  ||| S:339 E:347 ||| VBN
on  ||| S:347 E:350 ||| IN
using  ||| S:350 E:356 ||| VBG
cellular  ||| S:356 E:365 ||| JJ
and  ||| S:365 E:369 ||| CC
biochemical  ||| S:369 E:381 ||| JJ
methods  ||| S:381 E:389 ||| NNS
to  ||| S:389 E:392 ||| TO
investigate  ||| S:392 E:404 ||| VB
molecular  ||| S:404 E:414 ||| JJ
functions  ||| S:414 E:424 ||| NNS
in  ||| S:424 E:427 ||| IN
metabolic  ||| S:427 E:437 ||| JJ
pathways  ||| S:437 E:446 ||| NN
of  ||| S:446 E:449 ||| IN
parasite  ||| S:449 E:458 ||| JJ
infected  ||| S:458 E:467 ||| JJ
hosts ||| S:467 E:472 ||| NNS
.  ||| S:472 E:474 ||| .
Computational  ||| S:474 E:488 ||| NNP
approaches  ||| S:488 E:499 ||| VBZ
taking  ||| S:499 E:506 ||| VBG
advantage  ||| S:506 E:516 ||| NN
of  ||| S:516 E:519 ||| IN
high-throughput  ||| S:519 E:535 ||| JJ
biological  ||| S:535 E:546 ||| JJ
data  ||| S:546 E:551 ||| NNS
and  ||| S:551 E:555 ||| CC
topology  ||| S:555 E:564 ||| NN
of  ||| S:564 E:567 ||| IN
metabolic  ||| S:567 E:577 ||| JJ
pathways  ||| S:577 E:586 ||| NNS
have  ||| S:586 E:591 ||| VBP
a  ||| S:591 E:593 ||| DT
great  ||| S:593 E:599 ||| JJ
potential  ||| S:599 E:609 ||| NN
in  ||| S:609 E:612 ||| IN
revealing  ||| S:612 E:622 ||| VBG
the  ||| S:622 E:626 ||| DT
details  ||| S:626 E:634 ||| NNS
and  ||| S:634 E:638 ||| CC
mechanism  ||| S:638 E:648 ||| NN
of  ||| S:648 E:651 ||| IN
parasites-to-host  ||| S:651 E:669 ||| JJ
interactions ||| S:669 E:681 ||| NNS
.  ||| S:681 E:683 ||| .
A  ||| S:683 E:685 ||| DT
new  ||| S:685 E:689 ||| JJ
analytical  ||| S:689 E:700 ||| JJ
method  ||| S:700 E:707 ||| NN
was  ||| S:707 E:711 ||| VBD
designed  ||| S:711 E:720 ||| VBN
in  ||| S:720 E:723 ||| IN
this  ||| S:723 E:728 ||| DT
work  ||| S:728 E:733 ||| NN
to  ||| S:733 E:736 ||| TO
study  ||| S:736 E:742 ||| VB
host-parasite  ||| S:742 E:756 ||| JJ
interactions  ||| S:756 E:769 ||| NNS
in  ||| S:769 E:772 ||| IN
human  ||| S:772 E:778 ||| JJ
cells  ||| S:778 E:784 ||| NNS
infected  ||| S:784 E:793 ||| VBN
with  ||| S:793 E:798 ||| IN
Plasmodium  ||| S:798 E:809 ||| NNP
falciparum  ||| S:809 E:820 ||| NN
and  ||| S:820 E:824 ||| CC
Cryptosporidium  ||| S:824 E:840 ||| NNP
parvum ||| S:840 E:846 ||| NN
.  ||| S:846 E:848 ||| .
We  ||| S:848 E:851 ||| PRP
introduced  ||| S:851 E:862 ||| VBD
a  ||| S:862 E:864 ||| DT
new  ||| S:864 E:868 ||| JJ
method  ||| S:868 E:875 ||| NN
that  ||| S:875 E:880 ||| IN
analyzes  ||| S:880 E:889 ||| VBG
the  ||| S:889 E:893 ||| DT
host  ||| S:893 E:898 ||| NN
metabolic  ||| S:898 E:908 ||| NN
pathways  ||| S:908 E:917 ||| NN
in  ||| S:917 E:920 ||| IN
divided  ||| S:920 E:928 ||| JJ
parts ||| S:928 E:933 ||| NNS
:  ||| S:933 E:935 ||| :
host  ||| S:935 E:940 ||| NN
specific  ||| S:940 E:949 ||| JJ
subpathways  ||| S:949 E:961 ||| NN
and  ||| S:961 E:965 ||| CC
host-parasite  ||| S:965 E:979 ||| JJ
common  ||| S:979 E:986 ||| JJ
subpathways ||| S:986 E:997 ||| NN
.  ||| S:997 E:999 ||| .
Upon  ||| S:999 E:1004 ||| IN
analysis  ||| S:1004 E:1013 ||| NN
on  ||| S:1013 E:1016 ||| IN
gene  ||| S:1016 E:1021 ||| NN
expression  ||| S:1021 E:1032 ||| NN
data  ||| S:1032 E:1037 ||| NNS
from  ||| S:1037 E:1042 ||| IN
cells  ||| S:1042 E:1048 ||| NNS
infected  ||| S:1048 E:1057 ||| VBN
by  ||| S:1057 E:1060 ||| IN
Plasmodium  ||| S:1060 E:1071 ||| NNP
falciparum  ||| S:1071 E:1082 ||| NN
or  ||| S:1082 E:1085 ||| CC
Cryptosporidium  ||| S:1085 E:1101 ||| NNP
parvum ||| S:1101 E:1107 ||| NN
,  ||| S:1107 E:1109 ||| ,
we  ||| S:1109 E:1112 ||| PRP
found ||| S:1112 E:1117 ||| VBD
:  ||| S:1117 E:1119 ||| :
( ||| S:1119 E:1120 ||| -LRB-
i ||| S:1120 E:1121 ||| FW
)  ||| S:1121 E:1123 ||| -RRB-
six  ||| S:1123 E:1127 ||| CD
host-parasite  ||| S:1127 E:1141 ||| JJ
common  ||| S:1141 E:1148 ||| JJ
subpathways  ||| S:1148 E:1160 ||| NN
and  ||| S:1160 E:1164 ||| CC
four  ||| S:1164 E:1169 ||| CD
host  ||| S:1169 E:1174 ||| NN
specific  ||| S:1174 E:1183 ||| JJ
subpathways  ||| S:1183 E:1195 ||| NN
were  ||| S:1195 E:1200 ||| VBD
significantly  ||| S:1200 E:1214 ||| RB
altered  ||| S:1214 E:1222 ||| VBN
in  ||| S:1222 E:1225 ||| IN
plasmodium  ||| S:1225 E:1236 ||| JJ
infected  ||| S:1236 E:1245 ||| JJ
human  ||| S:1245 E:1251 ||| JJ
cells ||| S:1251 E:1256 ||| NNS
;  ||| S:1256 E:1258 ||| :
( ||| S:1258 E:1259 ||| -LRB-
ii ||| S:1259 E:1261 ||| LS
)  ||| S:1261 E:1263 ||| -RRB-
plasmodium  ||| S:1263 E:1274 ||| FW
utilized  ||| S:1274 E:1283 ||| FW
fatty  ||| S:1283 E:1289 ||| FW
acid  ||| S:1289 E:1294 ||| FW
biosynthesis  ||| S:1294 E:1307 ||| FW
and  ||| S:1307 E:1311 ||| CC
elongation ||| S:1311 E:1321 ||| NN
,  ||| S:1321 E:1323 ||| ,
and  ||| S:1323 E:1327 ||| CC
Pantothenate  ||| S:1327 E:1340 ||| NNP
and  ||| S:1340 E:1344 ||| CC
CoA  ||| S:1344 E:1348 ||| JJ
biosynthesis  ||| S:1348 E:1361 ||| NN
to  ||| S:1361 E:1364 ||| TO
obtain  ||| S:1364 E:1371 ||| VB
nutrients  ||| S:1371 E:1381 ||| VBN
from  ||| S:1381 E:1386 ||| IN
host  ||| S:1386 E:1391 ||| NN
environment ||| S:1391 E:1402 ||| NN
;  ||| S:1402 E:1404 ||| :
( ||| S:1404 E:1405 ||| -LRB-
iii ||| S:1405 E:1408 ||| LS
)  ||| S:1408 E:1410 ||| -RRB-
in  ||| S:1410 E:1413 ||| IN
Cryptosporidium  ||| S:1413 E:1429 ||| NNP
parvum  ||| S:1429 E:1436 ||| VBD
infected  ||| S:1436 E:1445 ||| JJ
cells ||| S:1445 E:1450 ||| NNS
,  ||| S:1450 E:1452 ||| ,
most  ||| S:1452 E:1457 ||| JJS
of  ||| S:1457 E:1460 ||| IN
the  ||| S:1460 E:1464 ||| DT
host-parasite  ||| S:1464 E:1478 ||| JJ
common  ||| S:1478 E:1485 ||| JJ
enzymes  ||| S:1485 E:1493 ||| NN
were  ||| S:1493 E:1498 ||| VBD
down-regulated ||| S:1498 E:1512 ||| JJ
,  ||| S:1512 E:1514 ||| ,
whereas  ||| S:1514 E:1522 ||| IN
the  ||| S:1522 E:1526 ||| DT
host  ||| S:1526 E:1531 ||| NN
specific  ||| S:1531 E:1540 ||| JJ
enzymes  ||| S:1540 E:1548 ||| JJ
up-regulated ||| S:1548 E:1560 ||| NN
;  ||| S:1560 E:1562 ||| :
( ||| S:1562 E:1563 ||| -LRB-
iv ||| S:1563 E:1565 ||| LS
)  ||| S:1565 E:1567 ||| -RRB-
the  ||| S:1567 E:1571 ||| DT
down-regulation  ||| S:1571 E:1587 ||| JJ
of  ||| S:1587 E:1590 ||| IN
common  ||| S:1590 E:1597 ||| JJ
subpathways  ||| S:1597 E:1609 ||| NN
in  ||| S:1609 E:1612 ||| IN
host  ||| S:1612 E:1617 ||| NN
cells  ||| S:1617 E:1623 ||| NNS
might  ||| S:1623 E:1629 ||| MD
be  ||| S:1629 E:1632 ||| VB
caused  ||| S:1632 E:1639 ||| VBN
by  ||| S:1639 E:1642 ||| IN
competition  ||| S:1642 E:1654 ||| NN
for  ||| S:1654 E:1658 ||| IN
the  ||| S:1658 E:1662 ||| DT
substrates  ||| S:1662 E:1673 ||| NN
and  ||| S:1673 E:1677 ||| CC
up-regulation  ||| S:1677 E:1691 ||| JJ
of  ||| S:1691 E:1694 ||| IN
host  ||| S:1694 E:1699 ||| NN
specific  ||| S:1699 E:1708 ||| JJ
subpathways  ||| S:1708 E:1720 ||| NN
may  ||| S:1720 E:1724 ||| MD
be  ||| S:1724 E:1727 ||| VB
stimulated  ||| S:1727 E:1738 ||| VBN
by  ||| S:1738 E:1741 ||| IN
parasite  ||| S:1741 E:1750 ||| JJ
infection ||| S:1750 E:1759 ||| NN
.  ||| S:1759 E:1761 ||| .
Results  ||| S:1761 E:1769 ||| NNS
demonstrated  ||| S:1769 E:1782 ||| VBD
a  ||| S:1782 E:1784 ||| DT
significantly  ||| S:1784 E:1798 ||| RB
coordinated  ||| S:1798 E:1810 ||| VBN
expression  ||| S:1810 E:1821 ||| NN
pattern  ||| S:1821 E:1829 ||| NN
between  ||| S:1829 E:1837 ||| IN
the  ||| S:1837 E:1841 ||| DT
two  ||| S:1841 E:1845 ||| CD
groups  ||| S:1845 E:1852 ||| NNS
of  ||| S:1852 E:1855 ||| IN
subpathways ||| S:1855 E:1866 ||| NN
.  ||| S:1866 E:1868 ||| .
The  ||| S:1868 E:1872 ||| DT
method  ||| S:1872 E:1879 ||| NN
helped  ||| S:1879 E:1886 ||| VBD
expose  ||| S:1886 E:1893 ||| VB
the  ||| S:1893 E:1897 ||| DT
impact  ||| S:1897 E:1904 ||| NN
of  ||| S:1904 E:1907 ||| IN
parasite  ||| S:1907 E:1916 ||| JJ
infection  ||| S:1916 E:1926 ||| NN
on  ||| S:1926 E:1929 ||| IN
host  ||| S:1929 E:1934 ||| NN
cell  ||| S:1934 E:1939 ||| NN
metabolism ||| S:1939 E:1949 ||| NN
,  ||| S:1949 E:1951 ||| ,
which  ||| S:1951 E:1957 ||| WDT
was  ||| S:1957 E:1961 ||| VBD
previously  ||| S:1961 E:1972 ||| RB
concealed  ||| S:1972 E:1982 ||| VBN
in  ||| S:1982 E:1985 ||| IN
the  ||| S:1985 E:1989 ||| DT
pathway  ||| S:1989 E:1997 ||| JJ
enrichment  ||| S:1997 E:2008 ||| JJ
analysis ||| S:2008 E:2016 ||| NN
.  ||| S:2016 E:2018 ||| .
Our  ||| S:2018 E:2022 ||| PRP$
approach  ||| S:2022 E:2031 ||| NN
revealed  ||| S:2031 E:2040 ||| VBD
detailed  ||| S:2040 E:2049 ||| JJ
subpathways  ||| S:2049 E:2061 ||| NN
and  ||| S:2061 E:2065 ||| CC
metabolic  ||| S:2065 E:2075 ||| JJ
information  ||| S:2075 E:2087 ||| NN
are  ||| S:2087 E:2091 ||| VBP
important  ||| S:2091 E:2101 ||| JJ
to  ||| S:2101 E:2104 ||| TO
the  ||| S:2104 E:2108 ||| DT
symbiosis  ||| S:2108 E:2118 ||| NN
in  ||| S:2118 E:2121 ||| IN
two  ||| S:2121 E:2125 ||| CD
kinds  ||| S:2125 E:2131 ||| NNS
of  ||| S:2131 E:2134 ||| IN
the  ||| S:2134 E:2138 ||| DT
apicomplex  ||| S:2138 E:2149 ||| JJ
parasites ||| S:2149 E:2158 ||| NNS
,  ||| S:2158 E:2160 ||| ,
and  ||| S:2160 E:2164 ||| CC
highlighted  ||| S:2164 E:2176 ||| VBD
its  ||| S:2176 E:2180 ||| PRP$
significance  ||| S:2180 E:2193 ||| NN
in  ||| S:2193 E:2196 ||| IN
research  ||| S:2196 E:2205 ||| NN
and  ||| S:2205 E:2209 ||| CC
understanding  ||| S:2209 E:2223 ||| NN
of  ||| S:2223 E:2226 ||| IN
parasite-host  ||| S:2226 E:2240 ||| JJ
interactions ||| S:2240 E:2252 ||| NNS
.  ||| S:2252 E:2254 ||| .
